Cargando…

Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial

INTRODUCTION: Neurodegeneration is a widely accepted contributor to the development of long-term disability in multiple sclerosis (MS). While current therapies in MS predominantly target inflammation and reduce relapse rate they have been less effective at preventing long-term disability. The identi...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKee, Justin B, Elston, John, Evangelou, Nikos, Gerry, Stephen, Fugger, Lars, Kennard, Christopher, Kong, Yazhuo, Palace, Jacqueline, Craner, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654308/ https://www.ncbi.nlm.nih.gov/pubmed/26553836 http://dx.doi.org/10.1136/bmjopen-2015-009200

Ejemplares similares

Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial—study protocol
por: Diem, Ricarda, et al.
Publicado: (2016)

Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial
por: Devanand, D P, et al.
Publicado: (2020)

Chiropractic spinal manipulative therapy for migraine: a study protocol of a single-blinded placebo-controlled randomised clinical trial
por: Chaibi, Aleksander, et al.
Publicado: (2015)

Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial
por: Katayama, Kanako, et al.
Publicado: (2015)

Study protocol for a phase II randomised, double-blind, placebo-controlled trial of perampanel as an antiepileptogenic treatment following acute stroke
por: Nicolo, John-Paul, et al.
Publicado: (2021)

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial
por: Brown, Morris J, et al.
Publicado: (2016)

Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)
por: Mandrioli, Jessica, et al.
Publicado: (2019)

Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol
por: Greenland, Julia C, et al.
Publicado: (2020)

Impact of a 12-week olfactory training programme in women with migraine with aura: protocol for a double-blind, randomised, placebo-controlled trial
por: Faria, Vanda, et al.
Publicado: (2023)

Repetitive transcranial magnetic stimulation for depression after basal ganglia ischaemic stroke: protocol for a multicentre randomised double-blind placebo-controlled trial
por: Tang, Ying, et al.
Publicado: (2018)

Efficacy of probucol on cognitive function in Alzheimer’s disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study)
por: Lam, Virginie, et al.
Publicado: (2022)

Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial
por: Vivash, Lucy, et al.
Publicado: (2021)

Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury
por: Koda, Masao, et al.
Publicado: (2018)

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis
por: Connick, Peter, et al.
Publicado: (2018)

Anterior Crural Neuritis
Publicado: (1913)

Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease
por: Wong, Charis, et al.
Publicado: (2022)

Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study
por: Payne, Thomas, et al.
Publicado: (2020)

Trial of Amiloride in Type 2 Diabetes With Proteinuria
por: Unruh, Mark L., et al.
Publicado: (2017)

Randomised, double-blind, placebo-controlled crossover study of single-dose guanfacine in unilateral neglect following stroke
por: Dalmaijer, Edwin S, et al.
Publicado: (2018)

The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis
por: Asseyer, Susanna, et al.
Publicado: (2023)

A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia
por: Vivash, Lucy, et al.
Publicado: (2020)

Rodent Models of Optic Neuritis
por: Redler, Yael, et al.
Publicado: (2020)

The incidence of vestibular neuritis in Italy
por: Mandalà, Marco, et al.
Publicado: (2023)

Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)
por: Yamada, Shinichiro, et al.
Publicado: (2018)

ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis
por: Kever, Anne, et al.
Publicado: (2020)

G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial)
por: Salamone, Paolina, et al.
Publicado: (2020)

Protocol for an exploratory, randomised, single-blind clinical trial of aerobic exercise to promote remyelination in multiple sclerosis
por: Wooliscroft, Lindsey, et al.
Publicado: (2023)

Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial
por: Falardeau, Julie, et al.
Publicado: (2019)

Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials
por: Vrinten, Charlotte, et al.
Publicado: (2015)

Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations
por: Kondo, Takayuki, et al.
Publicado: (2021)

The DEXA-CORT trial: study protocol of a randomised placebo-controlled trial of hydrocortisone in patients with brain tumour on the prevention of neuropsychiatric adverse effects caused by perioperative dexamethasone
por: Koning, Anne-Sophie C A M, et al.
Publicado: (2021)

Bilateral Parainfectious Optic Neuritis in Young Patient
por: Suparmaniam, Sruban, et al.
Publicado: (2022)

Optimizing vestibular neuritis management with modular strategies
por: Li, Fei, et al.
Publicado: (2023)

Tui Na for painful peripheral neuropathy in people with human immunodeficiency virus: A randomized, double-blind, placebo-controlled trial protocol
por: Zhu, Xingmei, et al.
Publicado: (2023)

Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial
por: Urbi, Berzenn, et al.
Publicado: (2019)

Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study
por: Carroll, Camille B, et al.
Publicado: (2019)

Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial
por: Polymeropoulos, Christos M., et al.
Publicado: (2022)

Efficacy and tolerability of oral gastrodin for medication overuse headache (EASTERN): Study protocol for a multicenter randomized double-blind placebo-controlled trial
por: Kong, Fanyi, et al.
Publicado: (2023)

Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)
por: Stam, Marloes, et al.
Publicado: (2018)

Efficacy and safety of butylphthalide for patients who had acute ischaemic stroke receiving intravenous thrombolysis or endovascular treatment (BAST trial): study protocol for a randomised placebo-controlled trial
por: Zhang, Xuelei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8dgm5skkjpergi2jfjpk7l1cpu